Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia
Clinical trial NCT05245539 · COMPLETED
Trial details
- NCT number
- NCT05245539
- Sponsor
- Cerevel Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-24
- Primary completion
- 2022-10-19
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.